BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15762191)

  • 1. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
    van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
    Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference in phenotype of the main Dutch SDHD founder mutations.
    van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.
    van Duinen N; Steenvoorden D; Kema IP; Jansen JC; Vriends AH; Bayley JP; Smit JW; Romijn JA; Corssmit EP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):209-14. PubMed ID: 19897674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
    Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
    JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paragangliomas in patients with mutations of the SDHD gene.
    Boedeker CC; Neumann HP; Ridder GJ; Maier W; Schipper J
    Otolaryngol Head Neck Surg; 2005 Mar; 132(3):467-70. PubMed ID: 15746863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
    King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
    de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
    Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.
    Hensen EF; Jansen JC; Siemers MD; Oosterwijk JC; Vriends AH; Corssmit EP; Bayley JP; van der Mey AG; Cornelisse CJ; Devilee P
    Eur J Hum Genet; 2010 Jan; 18(1):62-6. PubMed ID: 19584903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene.
    Havekes B; Corssmit EP; Jansen JC; van der Mey AG; Vriends AH; Romijn JA
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1245-8. PubMed ID: 17227803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomas.
    Yamashita R; Usui T; Hashimoto S; Suzuki H; Takahashi M; Honkura K; Iwamoto K; Kodama E; Tagami T; Naruse M; Shimatsu A; Kaise K
    Endocr J; 2009; 56(9):1129-35. PubMed ID: 19550080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
    Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
    J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.